Abstract
The Acquired Immunodeficiency Syndrome (AIDS) constitutes the main infectious cause of death in adults worldwide. Epidemiological data suggest the existence of differences in viral load and CD4+ T lymphocytes cell counts related to gender. Women have more favorable clinical and viro-immunological patterns than men in early infection, although once established the infection these patterns are reversed.
Increasing evidence shows that estradiol (E) and progesterone (P) participate in the regulation of several infections, such as that produced by human immunodeficiency virus (HIV). Several functions of these hormones involve the interaction with their intracellular receptors (ER and PR, respectively). During infection, E and P not only exert their action upon the immune system, but also directly act on the virus. Effects of E and P depend on their concentration or the phase of HIV infection but in general terms, they could exert a protective role against HIV infection.
Keywords: AIDS, estradiol, HIV, progesterone, isoforms, hormones, CXCR4, CCR5, TNF-α
Mini-Reviews in Medicinal Chemistry
Title:Role of Estradiol and Progesterone in HIV Susceptibility and Disease Progression
Volume: 12 Issue: 11
Author(s): E. Cabrera-Munoz, O.T. Hernandez-Hernandez and I. Camacho-Arroyo
Affiliation:
Keywords: AIDS, estradiol, HIV, progesterone, isoforms, hormones, CXCR4, CCR5, TNF-α
Abstract: The Acquired Immunodeficiency Syndrome (AIDS) constitutes the main infectious cause of death in adults worldwide. Epidemiological data suggest the existence of differences in viral load and CD4+ T lymphocytes cell counts related to gender. Women have more favorable clinical and viro-immunological patterns than men in early infection, although once established the infection these patterns are reversed.
Increasing evidence shows that estradiol (E) and progesterone (P) participate in the regulation of several infections, such as that produced by human immunodeficiency virus (HIV). Several functions of these hormones involve the interaction with their intracellular receptors (ER and PR, respectively). During infection, E and P not only exert their action upon the immune system, but also directly act on the virus. Effects of E and P depend on their concentration or the phase of HIV infection but in general terms, they could exert a protective role against HIV infection.
Export Options
About this article
Cite this article as:
Cabrera-Munoz E., Hernandez-Hernandez O.T. and Camacho-Arroyo I., Role of Estradiol and Progesterone in HIV Susceptibility and Disease Progression, Mini-Reviews in Medicinal Chemistry 2012; 12 (11) . https://dx.doi.org/10.2174/138955712802762185
DOI https://dx.doi.org/10.2174/138955712802762185 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mesenchymal Stromal Cell Secretome: Immunomodulation, Tissue Repair and Effects on Neurodegenerative Conditions
Current Stem Cell Research & Therapy Developmental Immunotoxicity (DIT) in Drug Safety Testing: Matching DIT Testing to Adverse Outcomes and Childhood Disease Risk
Current Drug Safety Applications of Umbilical Cord Derived Mesenchymal Stem Cells in Autoimmune and Immunological Disorders: From Literature to Clinical Practice
Current Stem Cell Research & Therapy Thymosin β4 Protein Therapy for Cardiac Repair
Current Pharmaceutical Design Classical to Current Approach for Treatment of Psoriasis: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Role of Gut Microbiota in Human Health and Diseases
Current Nutrition & Food Science Role of Nitric Oxide and Reactive Oxygen Species in Arthritis
Current Pharmaceutical Design Potential Relevance of Melatonin Against Some Infectious Agents: A Review and Assessment of Recent Research
Current Medicinal Chemistry The Protective Effects of Natural Products on Blood-Brain Barrier Breakdown
Current Medicinal Chemistry Statins And Stroke
Current Medicinal Chemistry Cytosolic Phospholipase A2 Inhibitors as Therapeutic Agents for Neural Cell Injury
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Recent Advances in Regulatory T Cell Therapy of Autoimmunity, Graft Rejection and Cancer
Recent Patents on Inflammation & Allergy Drug Discovery Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Other Anti- Inflammatory Agents in the Treatment of Neurodegenerative Disease
Current Alzheimer Research Heat Shock Proteins And Neuroprotection
Recent Patents on DNA & Gene Sequences New Insights of CTLA-4 into Its Biological Function in Breast Cancer
Current Cancer Drug Targets Possible Roles of Microglial Cells for Neurotoxicity in Clinical Neurodegenerative Diseases and Experimental Animal Models
Inflammation & Allergy - Drug Targets (Discontinued) Advances in the Immune Pathogenesis and Treatment of Multiple Sclerosis
Central Nervous System Agents in Medicinal Chemistry Mast Cells and Basophils: Trojan Horses of Conventional Lin- Stem/Progenitor Cell Isolates
Current Pharmaceutical Design Neuroprotective Properties of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) and its Lipid Ligands
Current Medicinal Chemistry The Use of Stem Cells in Regenerative Medicine for Parkinson’s and Huntington’s Diseases
Current Medicinal Chemistry